Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andexanet alfa Phase 3 study in Japan
jRCT2080224554Phase 3Completed
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3 trial of andexanet alfa. Started Feb 2019; status: completed.
02
Drugs
andexanet alfa
Beyond the preview
Go deeper on jRCT2080224554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224554.